Argos Therapeutics (ARGS) Misses Q3 EPS by 10c

Argos Therapeutics (NASDAQ: ARGS) reported Q3 EPS of ($0.83), $0.10 worse than the analyst estimate of ($0.73). Revenue for the quarter came in at $303 thousand versus the consensus estimate of $670 thousand.

For earnings history and earnings-related data on Argos Therapeutics (ARGS) click here.

You May Also Be Interested In

• Meta to pay up to $16.68 billion in mass social media settlement
• JinkoSolar (JKS) Misses Q2 EPS by RMB 7.10, Misses on Revenue
• LightInTheBox Holding (LITB) Reports Q2 EPS of $0.01